NRXP · NRX Pharmaceuticals, Inc. · Documents
$2.63
+0.01 (+0.38%)
At close · Oct 21
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“the Company has concluded that substantial doubt exists about the Company's ability to continue as a going concern for a period of at least twelve months from the date of issuance of these consolidated financial statements.”View the 10-Q filed Aug 14, 2026
Market Cap
$113.43M
Shares
43.30M
Volume · Oct 21
526.55K
Avg daily vol (3M)
874.71K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 10-Q | — | 2021-11-15 | 2021-09-30 | |
| 8-K | — | 2021-10-21 | 2021-10-15 | |
| 8-K | — | 2021-10-13 | — | |
| 8-K | — | 2021-09-10 | 2021-09-03 | |
| S-1 | — | 2021-09-03 | — | |
| 8-K | — | 2021-08-24 | 2021-08-19 | |
| 8-K | — | 2021-08-20 | 2021-08-19 | |
| 8-K | — | 2021-08-19 | 2021-08-18 | |
| 10-Q | — | 2021-08-16 | 2021-06-30 | |
| S-1/A | — | 2021-07-06 | — | |
| S-1 | — | 2021-06-25 | — | |
| 8-K | — | 2021-05-28 | 2021-05-24 | |
| 8-K | — | 2021-05-28 | 2021-05-24 | |
| 8-K | — | 2021-05-26 | 2021-05-24 | |
| 8-K | — | 2021-05-24 | 2021-05-21 | |
| 10-Q | — | 2021-05-21 | 2021-03-31 | |
| S-4/A | — | 2021-05-21 | — | |
| S-4/A | — | 2021-05-20 | — | |
| S-4/A | — | 2021-05-19 | — | |
| NT 10-Q | — | 2021-05-14 | 2021-03-31 | |
| 10-K/A | — | 2021-05-14 | 2020-12-31 | |
| S-4/A | — | 2021-05-12 | — | |
| 8-K | — | 2021-05-11 | 2021-05-06 | |
| 8-K | — | 2021-04-29 | 2021-04-28 | |
| 8-K | — | 2021-04-21 | — | |
| 8-K | — | 2021-04-19 | — | |
| S-4/A | — | 2021-04-16 | — | |
| DEFA14A | — | 2021-04-08 | — | |
| DEF 14A | — | 2021-04-01 | 2021-04-21 | |
| NT 10-K | — | 2021-04-01 | 2020-12-31 | |
| 10-K | — | 2021-04-01 | 2020-12-31 | |
| 8-K | — | 2021-03-29 | 2021-03-09 | |
| 8-K | — | 2021-03-22 | 2021-03-19 | |
| PRE 14A | — | 2021-03-22 | 2021-03-19 | |
| 8-K | — | 2021-03-15 | 2021-03-12 | |
| 8-K | — | 2021-02-24 | 2021-02-23 | |
| 8-K | — | 2021-02-09 | — | |
| S-4 | — | 2021-01-27 | — | |
| 8-K | — | 2021-01-20 | 2021-01-15 | |
| 8-K | — | 2021-01-12 | 2021-01-11 | |
| 8-K/A | — | 2021-01-11 | 2021-01-04 | |
| 8-K | — | 2020-12-18 | — | |
| 8-K | — | 2020-12-17 | 2020-12-13 | |
| DEFA14A | — | 2020-12-15 | — | |
| DEF 14A | — | 2020-12-07 | 2020-12-18 | |
| PRE 14A | — | 2020-11-25 | 2020-12-18 | |
| 8-K | — | 2020-11-25 | 2020-11-23 | |
| 10-Q | — | 2020-11-16 | 2020-09-30 | |
| 10-Q | — | 2020-08-14 | 2020-06-30 | |
| 8-K | — | 2020-07-24 | 2020-07-23 |
Showing 151–200 of 209 filings